Projectes

IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.

Paraules clau

Grup de recerca

Investigador/a

Des del

Fins el

High-throughput synthetic biology platform for surveillance and therapeutics development against current and future SARS-Coronaviruses

Estatus del projecte

Vigent

Inici/Fi

2021

/

2024

Investigador/a principal

Maria Salgado Bernal

Entitats participants

IrsiCaixa, IBE (CSIC:UPF), UPF

Línia estratègica

Càncer

Malalties infeccioses emergents

Entitat finançadora

Fundació "La Marató" de TV3
Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER)

Estatus del projecte

Vigent

Inici/Fi

2022

Investigador/a principal

Julia García Prado

Javier Martínez-Picado

Entitats participants

IrsiCaixa, IGTP

Entitat finançadora

ISCIII
EU Research Scholars Program in HIV

Estatus del projecte

Vigent

Inici/Fi

2021

/

2023

Investigador/a principal

Sara Morón López

Entitats participants

IrsiCaixa

Línia estratègica

Malalties infeccioses globals

Entitat finançadora

GILEAD
Reversing Immune Dysfunction for HIV-1 eradication

Estatus del projecte

Vigent

Inici/Fi

2021

/

2026

Investigador/a principal

Javier Martínez-Picado

Maria Salgado Bernal

Entitats participants

IrsiCaixa, Emory University, University of Southern California, Scripps Research College

Línia estratègica

Malalties infeccioses globals

Entitat finançadora

National Institutes of Health (NIH)
Elimination of the HIV latent reservoir by using novel anti-CD4 chimeric antigen receptor T cells

Estatus del projecte

Vigent

Inici/Fi

2021

/

2024

Investigador/a principal

Maria Salgado Bernal

Entitats participants

IrsiCaixa, Josep Carreras Leukaemia Research Institute

Línia estratègica

Immunopatologia de les malalties

Entitat finançadora

Spanish Ministry of Science and Innovation
Treatment with immunological checkpoint inhibitors of HIV-infected subjects with cancer

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Merck Sharp & Dohme de España, SA (MSD); ref IISP 57699
Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion

Estatus del projecte

Vigent

Inici/Fi

2019

/

2020

Investigador/a principal

Javier Martínez-Picado

Jakub Chojnacki

Entitat finançadora

European Comission (H2020)
SIGTECH - New technologies mimicking virus-cell interaction to fight infectious diseases

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Nuria Izquierdo Useros

Entitat finançadora

Grifols
VIROCURE - Cutting edge strategies on HIV cure

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Grifols
Exploratory, open-label, randomized clinical trial to assess the efficacy of first-line dual vs. triple antiretroviral therapy in HIV-1 reservoir and in peripheral compartments in HIV-infected patients

Estatus del projecte

Vigent

Inici/Fi

2019

/

2021

Investigador/a principal

Javier Martínez-Picado

Entitats participants

AIDS Research Institute IrsiCaixa

Línia estratègica

Malalties infeccioses globals

Entitat finançadora

ViiV Healthcare